PIK3CA and breast carcinoma: The presence of PIK3CA mutations represents an independent adverse prognostic factor in breast carcinoma (Sobhani et al., 2018) and has been associated with more aggressive disease and poor outcomes in metastatic disease (Fitzgerald et al., 2019).